These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7329802)

  • 1. [Heparin and its metamorphoses].
    Choay J
    Nouv Rev Fr Hematol (1978); 1981; 23(5):253-6. PubMed ID: 7329802
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin.
    Jaques LB
    New Istanbul Contrib Clin Sci; 1973 Oct; 10(4):208-21. PubMed ID: 4132870
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heparin; current viewpoints of an old concept].
    Albada J; Nieuwenhuis HK; Sixma JJ
    Ned Tijdschr Geneeskd; 1987 Dec; 131(50):2294-9. PubMed ID: 3320768
    [No Abstract]   [Full Text] [Related]  

  • 4. [Physico-chemical and biological peculiarities of thyrocalcitonin complexes with high molecular weight compounds].
    Stekol'nikov LI; Katkovskiĭ SB; Tepelina OM; Konopatskaia VM; Abdukarimov A; Egorova TV
    Vopr Med Khim; 1969; 15(3):276-9. PubMed ID: 5805161
    [No Abstract]   [Full Text] [Related]  

  • 5. Some recent developments in the pharmacology of heparin.
    Coon WW
    J Clin Pharmacol; 1979 Jul; 19(7):337-49. PubMed ID: 479378
    [No Abstract]   [Full Text] [Related]  

  • 6. [The anticoagulant properties of different heparin fractions].
    Bychko SM; Kharlamova VN
    Biull Eksp Biol Med; 1975 Feb; 79(2):61-3. PubMed ID: 1131415
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterogeneity of heparin.
    Walton PL; Ricketts CR; Bangham DR
    Br J Haematol; 1966 May; 12(3):310-25. PubMed ID: 5935988
    [No Abstract]   [Full Text] [Related]  

  • 8. Overview: from heparin to low molecular weight heparin: beyond anticoagulation.
    Mousa SA; Fareed J
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1077-80. PubMed ID: 11892916
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparins--anionic polyelectrolyte drugs.
    Jaques LB
    Pharmacol Rev; 1979 Jun; 31(2):99-166. PubMed ID: 399524
    [No Abstract]   [Full Text] [Related]  

  • 10. Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin.
    Young E; Wells P; Holloway S; Weitz J; Hirsh J
    Thromb Haemost; 1994 Mar; 71(3):300-4. PubMed ID: 8029793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of inhibitors and the mechanisms of action of antithrombin III.
    Rosenberg RD; Oosta GM
    Prog Clin Biol Res; 1981; 72():179-203. PubMed ID: 7335648
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical and pharmacologic profile of defined molecular weight fractions of heparin.
    Hoppensteadt DA; Jeske W; Ahsan A; Walenga JM; Fareed J
    Semin Thromb Hemost; 1993; 19 Suppl 1():12-9. PubMed ID: 8362260
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular nature of histamine-heparin complex].
    Erzinkian KL; Alaverdian KG; Nizhniĭ SV
    Izv Akad Nauk SSSR Biol; 1977; (6):813-8. PubMed ID: 604371
    [No Abstract]   [Full Text] [Related]  

  • 14. [The molecular mechanism of the fibrinogen--heparin complex formation reaction].
    Rozenfel'd MA; Erzinkain KL; Piruzian LA
    Izv Akad Nauk SSSR Biol; 1975; (3):419-27. PubMed ID: 1214026
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution to the analytical chemistry of heparin. IV. Indirect polarographic evaluation of heparin].
    Vachek J; Eckschlager K; Nekvasilová M
    Cesk Farm; 1966 Jun; 15(5):260-1. PubMed ID: 5946144
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of heparin binding to human leukocytes using a fluorescein-5-isothiocyanate labeled heparin fragment.
    Harenberg J; Malsch R; Piazolo L; Huhle G; Heene DL
    Cytometry; 1996 Jan; 23(1):59-66. PubMed ID: 14650442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crossreactivity studies between sera of patients with heparin associated thrombocytopenia and a new low molecular weight heparin, reviparin.
    Greinacher A; Feigl M; Mueller-Eckhardt C
    Thromb Haemost; 1994 Oct; 72(4):644-5. PubMed ID: 7878646
    [No Abstract]   [Full Text] [Related]  

  • 18. [The relationship between the physical chemical properties and the anticoagulating capacity of heparin].
    Nispen tot Pannerden EB
    Pharm Weekbl; 1968 Dec; 103(51):1353-5. PubMed ID: 5715860
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin and low molecular weight heparin in thrombosis and beyond.
    Mousa SA
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An active fraction of unfractionated heparin from a natural source is recognized by the first component of the complement system.
    Calabrese GC; Leocatanieto F; Recondo EF; Fernandez de Recondo ME
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL119-23. PubMed ID: 11936856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.